Fdc Drugs

The Delhi High Court today said that no coercive steps be taken against drug companies for fixed dose combination (FDC)s already in market, subject to stopping of their manufacturing.

The Supreme Court has allowed the sale of Saridon and two other drugs for now after the government had banned 328 combination drugs last week. The top court's order comes on a petition filed by the drug makers. While lifting the stay, the court sought the centre's reply on petitions against the order to ban fixed-dose combination or FDCs manufactur...

Painkillers like Saridon and 328 other fixed dose combination drugs had been banned by the healthy ministry last week. The Supreme Court however has allowed sale of Saridon and 2 other drugs for now.

Painkiller Saridon and skin cream Panderm are among 328 fixed-dose combination or FDC drugs banned by the government to stop their "irrational use". The health ministry says the ingredients in these medicines do not markedly add to the benefits that people can get from taking them. The order immediately bans the manufacture, marketing and sale of s...

The Delhi High Court is likely to pronounce today its verdict on 454 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.

Drug firm FDC Ltd has received two observations from the US Food and Drug Administration (FDA) related to current good manufacturing practice (cGMP) norms for its manufacturing facility situated at Waluj in Maharashtra.

Indian pharmaceutical market grew 7.7 per cent in May compared with 3.5 per cent in April, but the ban on fixed-dose combination (FDC) drugs remains an overhang, says a report.

The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.

Indian drug industry will see moderation in growth due to slowing of business in the US market with reduction in the number of large size drugs going off patent, increased competition and generic adoption reaching saturation levels, Icra said on Thursday.

Government on Thursday told Delhi High Court that the decision to ban 344 fixed dose combination (FDC) drugs was taken keeping in view "safety, efficacy and rationality" of these medicines.

Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.

In what could be the Maggi moment for the pharma majors, the Delhi High Court will today hear cases filed by various pharmaceutical companies against a ban imposed by the central government on 344 drug combinations.

Drug major Merck Ltd today said it is exploring all options to counter the ban on its two cough syrups, Cosome Expectorant and Cosome LCD, manufacturing and sales of which have stopped.

Delhi High Court on Friday stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

The MCA study covered medicines manufactured/marketed by Ranbaxy, Dr Reddy's Lab, Wyeth, FDC, Alembic, Glaxomithkline, Pfizer, USV, ELder Pharma, Zydus Cadila, Wochardt and Cipla.

The Delhi High Court today said that no coercive steps be taken against drug companies for fixed dose combination (FDC)s already in market, subject to stopping of their manufacturing.

The Supreme Court has allowed the sale of Saridon and two other drugs for now after the government had banned 328 combination drugs last week. The top court's order comes on a petition filed by the drug makers. While lifting the stay, the court sought the centre's reply on petitions against the order to ban fixed-dose combination or FDCs manufactur...

Painkillers like Saridon and 328 other fixed dose combination drugs had been banned by the healthy ministry last week. The Supreme Court however has allowed sale of Saridon and 2 other drugs for now.

Painkiller Saridon and skin cream Panderm are among 328 fixed-dose combination or FDC drugs banned by the government to stop their "irrational use". The health ministry says the ingredients in these medicines do not markedly add to the benefits that people can get from taking them. The order immediately bans the manufacture, marketing and sale of s...

The Delhi High Court is likely to pronounce today its verdict on 454 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.

Drug firm FDC Ltd has received two observations from the US Food and Drug Administration (FDA) related to current good manufacturing practice (cGMP) norms for its manufacturing facility situated at Waluj in Maharashtra.

Indian pharmaceutical market grew 7.7 per cent in May compared with 3.5 per cent in April, but the ban on fixed-dose combination (FDC) drugs remains an overhang, says a report.

The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.

Indian drug industry will see moderation in growth due to slowing of business in the US market with reduction in the number of large size drugs going off patent, increased competition and generic adoption reaching saturation levels, Icra said on Thursday.

Government on Thursday told Delhi High Court that the decision to ban 344 fixed dose combination (FDC) drugs was taken keeping in view "safety, efficacy and rationality" of these medicines.

Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.

In what could be the Maggi moment for the pharma majors, the Delhi High Court will today hear cases filed by various pharmaceutical companies against a ban imposed by the central government on 344 drug combinations.

Drug major Merck Ltd today said it is exploring all options to counter the ban on its two cough syrups, Cosome Expectorant and Cosome LCD, manufacturing and sales of which have stopped.

Delhi High Court on Friday stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

The MCA study covered medicines manufactured/marketed by Ranbaxy, Dr Reddy's Lab, Wyeth, FDC, Alembic, Glaxomithkline, Pfizer, USV, ELder Pharma, Zydus Cadila, Wochardt and Cipla.